<DOC>
	<DOCNO>NCT00109278</DOCNO>
	<brief_summary>The purpose study test safety measles , mumps , rubella study vaccine make new measles stock seed ( component vaccine make 2003 ) rHA ( recombinant human albumin ) .</brief_summary>
	<brief_title>A Measles , Mumps , Rubella Investigational Vaccine Trial ( V205C-010 ) ( COMPLETED )</brief_title>
	<detailed_description>The duration treatment 6 week .</detailed_description>
	<mesh_term>Measles</mesh_term>
	<mesh_term>Vaccines</mesh_term>
	<criteria>Healthy child 12 18 month age . Previous receipt measles , mumps , rubella and/or varicella vaccine . Prior infection exposure ( within last 4 week ) measles , mumps , rubella , varicella and/or zoster . Any medical condition might interfere immune response give vaccine ( include HIV infection and/or cancer ) undergone immunosuppressive ( weaken body 's ability fight infection ) therapy . History seizure ( convulsion ) Allergies component vaccine , include sorbitol , gelatin , neomycin . A recent ( within last 3 day ) illness result fever ( underarm temperature great 99.5° F [ 37.5° C ] ) .</criteria>
	<gender>All</gender>
	<minimum_age>12 Months</minimum_age>
	<maximum_age>18 Months</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prevention Measles</keyword>
</DOC>